Showing results (141-150 of 189) with videos related to
Sort By:
Pageof 19
Brachytherapy|October 29, 2008
Prostate cancer control and survival in Vietnam veterans exposed to Agent OrangeLydia Everly, Gregory S Merrick, Zachariah A Allen, et al.American Journal of Clinical Oncology|February 7, 2012
Transperineal template-guided mapping biopsy as a staging procedure to select patients best suited for active surveillanceAl V Taira, Gregory S Merrick, Abbey Bennett, et al.American Journal of Clinical Oncology|December 9, 2008
Effects of the time interval between prostate brachytherapy and postimplant dosimetric evaluation in community practice: analysis of the Pro-Qura databasePeter F Orio, Gregory S Merrick, Peter Grimm, et al.Reviews in Urology|November 14, 2013
The case for hypofractionation of localized prostate cancerWinnifred M Wong, Kent E WallnerUrology|February 20, 2004
Epididymitis after transrectal ultrasound-guided needle biopsy of prostate glandJoseph G Donzella, Gregory S Merrick, David J Lindert, et al.Brachytherapy|February 8, 2007
Initial analysis of Pro-Qura: a multi-institutional database of prostate brachytherapy dosimetryGregory S Merrick, Peter D Grimm, John Sylvester, et al.Brachytherapy|September 13, 2008
Inter-institutional variation of implant activity for permanent prostate brachytherapyJesse N Aronowitz, Juanita M Crook, Jeff M Michalski, et al.American Journal of Clinical Oncology|December 17, 2009
Optimal equations for describing the relationship between prostate volume, number of sources, and total activity in permanent prostate brachytherapyJesse N Aronowitz, Jeff M Michalski, Gregory S Merrick, et al.Brachytherapy|February 8, 2007
American Brachytherapy Society recommends no change for prostate permanent implant dose prescriptions using iodine-125 or palladium-103Mark J Rivard, Wayne M Butler, Phillip M Devlin, et al.Urologic Nursing|August 31, 2006
Cholesterol, cholesterol-lowering agents/statins, and urologic disease: Part III--A rapid review of FDA-approved cholesterol-lowering agentsMark A Moyad, Gregory S MerrickPageof 19